Chemoinformaics analysis of 2’-hydroxy cinnamaldehyde
| Molecular Weight | 302.08 | nRot | 4 |
| Heavy Atom Molecular Weight | 294.016 | nRig | 9 |
| Exact Molecular Weight | 300.959 | nRing | 1 |
| Solubility: LogS | -3.808 | nHRing | 0 |
| Solubility: LogP | 2.488 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 30.1943 |
| nHD | 1 | BPOL | 13.1757 |
| QED | 0.303 |
| Synth | 3.059 |
| Natural Product Likeliness | -0.331 |
| NR-PPAR-gamma | 0.474 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.134 |
| CACO-2 | -4.499 |
| MDCK | 0.0000713 |
| BBB | 0.685 |
| PPB | 0.957681 |
| VDSS | 0.645 |
| FU | 0.0244915 |
| CYP1A2-inh | 0.96 |
| CYP1A2-sub | 0.593 |
| CYP2c19-inh | 0.546 |
| CYP2c19-sub | 0.39 |
| CYP2c9-inh | 0.354 |
| CYP2c9-sub | 0.835 |
| CYP2d6-inh | 0.152 |
| CYP2d6-sub | 0.33 |
| CYP3a4-inh | 0.316 |
| CYP3a4-sub | 0.148 |
| CL | 1.321 |
| T12 | 0.643 |
| hERG | 0.02 |
| Ames | 0.842 |
| ROA | 0.761 |
| SkinSen | 0.937 |
| Carcinogencity | 0.814 |
| EI | 0.78 |
| Respiratory | 0.883 |
| NR-Aromatase | 0.759 |
| Antiviral | No |
| Prediction | 0.863468 |